Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04759989 · ClinicalTrials.gov registry record · NA
Fluid Resuscitation in Septic Shock Patients With BMI Elevation
A NA study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT04759989: Clinical Trial NA study, sponsored by Wake Forest University Health Sciences.
NCT04759989 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04759989, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
To explore the safety and feasibility of alternative fluid resuscitation strategies in obese patients with septic shock.
Primary Outcome
percentage of of patients with actual volume received within 10% of target fluid volume.
Interventions
- PROCEDURE Actual Body Weight Dosing
- PROCEDURE Adjusted Body Weight Dosing
- PROCEDURE Ideal Body Weight Dosing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2022-05-25 |
| Phase | NA |
Why NCT04759989 stopped before completion
NCT04759989 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 3 interventions - of which Actual Body Weight Dosing is the first listed.
NCT04759989 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04759989 about?
NCT04759989 is a clinical study titled "Fluid Resuscitation in Septic Shock Patients With BMI Elevation". To explore the safety and feasibility of alternative fluid resuscitation strategies in obese patients with septic shock.
What is the current status of trial NCT04759989?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2021-06-01. Estimated completion is 2022-05-25.
What interventions are being tested in trial NCT04759989?
The interventions under investigation include: Actual Body Weight Dosing (PROCEDURE), Adjusted Body Weight Dosing (PROCEDURE), Ideal Body Weight Dosing (PROCEDURE).
Who is sponsoring clinical trial NCT04759989?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04759989's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI